SLU-PP-332 10MG
SLU-PP-332 10MG | ESTROGEN-RELATED RECEPTOR (ERR) AGONIST
SLU-PP-332 is a first-in-class small molecule ERR agonist, frequently referred to in literature as an "exercise mimetic." This compound is at the forefront of metabolic research, specifically targeting the Estrogen-Related Receptors ($\alpha, \beta, \gamma$) to program skeletal muscle into a more oxidative, fatigue-resistant state.
Key Research Mechanisms
-
Oxidative Fiber Transformation: Research focuses on SLU-PP-332’s ability to promote the transition of muscle fibers toward "Type I" slow-twitch characteristics, which are inherently more resistant to fatigue.
-
Mitochondrial Biogenesis: It is studied for its potent effect on increasing mitochondrial density and efficiency within skeletal muscle, enhancing the cell's ability to burn fat for fuel.
-
Metabolic Rate Enhancement: Investigations suggest that SLU-PP-332 increases energy expenditure and oxygen consumption, making it a critical subject for research into obesity and metabolic syndrome.
-
Endurance & Performance Modeling: Clinical research utilizes this compound to observe significant increases in physical endurance and performance levels in the absence of traditional physical training.
Product Specifications
-
Concentration: 10mg
-
Form: Lyophilized Powder
-
Purity: >99% High-Performance Liquid Chromatography (HPLC) verified.
-
Target: Pan-ERR Agonist ($\text{ERR}\alpha$, $\text{ERR}\beta$, $\text{ERR}\gamma$).
-
Storage: Store at -20°C for long-term stability. Once reconstituted, the solution should be kept refrigerated and shielded from light.
LNGVIX Precision Synthesis
SLU-PP-332 from LNGVIX is manufactured with monolithic precision, ensuring that the molecular structure is optimized for high-fidelity binding to nuclear receptors in laboratory models.
LABORATORY PRECAUTION: This product is intended for laboratory research use only. It is not for human consumption, diagnostic, or therapeutic use. All research protocols must be executed by qualified laboratory professionals.